• <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
      <b id="1ykh9"><small id="1ykh9"></small></b>
    1. <b id="1ykh9"></b>

      1. <button id="1ykh9"></button>
        <video id="1ykh9"></video>
      2. west china medical publishers
        Keyword
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Keyword "注射" 283 results
        • STUDY OF FASCIOTOMY FOR THE TREATMENT FROM INJECTION SCIATIC NERVE INJURY

          Nine cases of sciatic nerve from injection hadbeen treated by fasciotomy. The skin temperatureof the diseased limb immediately raised 1-2℃ fol-lowing operation. The cutaneous sensation began torecover 2-3 days after operation. Two cases ofplantar ulcer recovered one month post operation.Five of the eight cases of paralysis of muscle in-nervated by the common peroneal nerve recoveredto normal. The etiology,pathology, and therapeuticmethods of the nerve injury caused by drug injec-tion were discused.

          Release date:2016-09-01 11:41 Export PDF Favorites Scan
        • 參附注射液對二尖瓣置換術患者圍術期心肌酶及血流動力學的影響

          目的 探討參附注射液對體外循環二尖瓣置換術(MVR)患者圍手術期心肌酶及血流動力學的影響。方法 將40例行MVR的患者隨機分為實驗組(n=20)和對照組(n=20),實驗組于麻醉誘導后手術開始前、術后12、36和60h經靜脈滴注參附注射液(1ml/kg)和250ml生理鹽水;對照組輸入等量的生理鹽水。于術前、術后2、8、24、48和72h取靜脈血檢測兩組血漿肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)含量,并觀察血流動力學指標變化及術中、術后血管活性藥物的用量。結果術后2、8、24、48和72h對照組血漿CK和CK—MB值均高于實驗組(Plt;0.05)。主動脈阻斷前、心臟復跳后30min、手術結束時實驗組平均動脈壓(MAP)均高于對照組(Plt;0.05)。術中和術后住ICU期間實驗組多巴胺和氨力農的用量均低于對照組(Plt;0.05)。結論 參附注射液能減輕心內直視手術患者的心肌損傷,對心功能有一定的保護作用。

          Release date:2016-08-30 06:23 Export PDF Favorites Scan
        • 玻璃體腔注射曲安奈德治療非動脈炎性前部缺血性視神經病變的臨床觀察

          Release date:2016-09-02 05:37 Export PDF Favorites Scan
        • Effectiveness of dorsal perforator flap of cross-finger proper digital artery in treatment of high-pressure injection injuries of the finger

          Objective To investigate the effectiveness of dorsal perforator flap of cross-finger proper digital artery in the treatment of finger soft tissue defect caused by high-pressure injection injury. MethodsBetween July 2011 and June 2020, 14 cases of finger soft tissue defect caused by high-pressure injection injury were repaired with dorsal perforator flap of cross-finger proper digital artery. All patients were male, with a mean age of 36 years (range, 22-56 years). The defects were located on the index finger in 8 cases, middle finger in 4 cases, and ring finger in 2 cases. The causes of injury include 8 cases of emulsion paint injection, 4 cases of oil paint injection, and 2 cases of cement injection. The time from injury to debridement was 2-8 hours, with a mean time of 4.5 hours. The soft tissue defects sized from 4.0 cm×1.2 cm to 6.0 cm×2.0 cm. The flaps sized from 4.5 cm×1.5 cm to 6.5 cm×2.5 cm. The donor site of the flap was repaired with skin graft. The pedicle was cut off at 3 weeks after operation, and followed by functional exercise. ResultsAll flaps and skin grafts at donor sites survived, and the wounds healed by first intention. Twelve patients were followed-up 16-38 months (mean, 22.6 months). The texture and appearance of all flaps were satisfactory. The color and texture of the flaps were similar to those of the surrounding tissues. The two-point discrimination of the flap was 10-12 mm, with a mean of 11.5 mm. There were different degrees of cold intolerance at the end of the affected fingers. At last follow-up, the finger function was evaluated according to the Upper Extremity Functional Evaluation Standard set up by Hand Surgery Branch of Chinese Medical Association, 3 cases were excellent, 8 cases were good, and 1 case was poor. Conclusion The dorsal perforator flap of cross-finger proper digital artery can effectively repair finger soft tissue defect caused by high-pressure injection injury. The operation was simple, and the appearance and function of the finger recover well.

          Release date:2023-09-07 04:22 Export PDF Favorites Scan
        • 兔眼玻璃體腔注射國產美羅培南的視網膜毒性研究

          Release date:2016-09-02 05:52 Export PDF Favorites Scan
        • Preliminary study on the efficacy of subretinal injection of Aflibercept in the treatment of refractory polypoidal choroidal vasculopathy

          Objective To observe the efficacy and safety of subretinal injection of Aflibercept for the treatment of refractory or recurrent polypoidal choroidal vasculopathy (PCV). MethodsA prospective clinical research. From January to June 2022, 18 patients of 18 eyes with PCV diagnosed in The Affiliated Eye Hospital of Nanchang University were included in the study. All patients underwent best corrected visual acuity (BCVA), indocyanine green angiography and optical coherence tomography (OCT). The BCVA examination was performed using the international standard visual acuity chart, which was converted to logarithm of the minimum angle of resolution (logMAR) visual acuity during statistics. The large choroidal vessel thickness (LVCT), central retinal thickness (CRT), sub-foveal choroidal thickness (SFCT) and retinal pigment epithelium detachment (PED) height were measured by enhanced depth imaging technique of OCT. The choroidal vascular index (CVI) was calculated. There were 18 patients of 18 eyes, 11 males of 11 eyes and 7 females of 7 eyes. The age was (64.22±3.86) years old. The disease duration was (5.22±1.80) years. The patient had received intravitreal injection of anti-vascular endothelial growth factor (VEGF) drugs for (7.72±1.36) times. The logMAR BCVA of the affected eyes was 1.28±0.25. The SFCT, CRT, LVCT, PED height were (436.56±9.80), (432.44±44.29), (283.78±27.10), (342.44±50.18) μm, respectively, and CVI was 0.65±0.01. All eyes were treated with a single subretinal injection of 40 mg/ml Aflibercept 0.05 ml (including Aflibercept 2.0 mg). According to the results of OCT and BCVA after treatment, the lesions were divided into active type and static type. The active lesions were treated with intravitreal injection of Aflibercept at the same dose as before. Quiescent lesions were followed up. Examinations were performed 1-3, 6, 9 and 12 months after treatment using the same equipment and methods before treatment. The BCVA, LVCT, CRT, SFCT, PED height, CVI, interretinal or subretinal fluid, lesion regression rate, injection times, and complications during and after treatment were observed. The BCVA, SFCT, CRT, LVCT, PED height and CVI before and after treatment were compared by repeated measures analysis of variance. ResultsEighteen eyes received subretinal and/or intravitreal injection of Aflibercept (1.61±0.85) times (1-4 times). At the last follow-up, the polypoid lesions regressed in 4 eyes and PED disappeared in 1 eye. Compared with before treatment, BCVA (F=50.298) gradually increased, CRT (F=25.220), PED height (F=144.16), SFCT (F=69.77), LVCT (F=136.69), CVI (F=72.70) gradually decreased after treatment. The differences were statistically significant (P<0.001). Macular hole occurred in 1 eye after treatment, and the hole closed spontaneously 3 months after treatment. No serious complications such as retinal tear, retinal detachment, endophthalmitis and vitreous hemorrhage occurred during and after treatment. ConclusionSubretinal injection of Aflibercept is safe and effective in the treatment of refractory PCV.

          Release date:2024-03-06 03:23 Export PDF Favorites Scan
        • 參附注射液對行顱內動脈瘤夾閉術患者血清SOD,MDA,S-100β 蛋白的影響

          目的:觀察參附注射液對行顱內動脈瘤夾閉術患者MDA,SOD,S-100β蛋白(S-100β)的影響,以探討其腦保護的機制。方法:行顱內動脈瘤夾閉術患者隨機分為參附組(Ⅰ組)和對照組(Ⅱ組),分別于術前12 h和手術日麻醉誘導前30 min給予參附注射液 1 mL/kg和生理鹽水1 mL/kg,在于氣管插管后即刻T1, 夾閉動脈瘤前T2,動脈瘤夾閉后30 min T3,分別緩慢抽取頸內靜脈球部血樣5 mL以備檢測SOD活性和MDA,S-100β的含量。 結果:參附組(Ⅰ組)MDA和S-100β含量明顯低于對照組(Ⅱ組),Plt;0.05,SOD活性明顯高于對照組(Ⅱ組), Plt;0.05。結論:參附注射液可提高SOD活性,降低MDA和S-100β的含量,從而對行顱內動脈瘤夾閉術患者有腦保護作用。

          Release date:2016-09-08 09:56 Export PDF Favorites Scan
        • Influence of Radix Salviae Miltiorrhizae Injection upon NF-κB in Rat with Severe Acute Pancreatitis

          Objective To investigate the mechanism of radix salviae miltiorrhizae (RSM) injection in treatment of pancreatitis through observing the changes of activity of nuclear factor-kappa B (NF-κB) in pancreas of rats with severe acute pancreatitis (SAP) and the influence of RSM injection upon NF-κB in pancreas tissue. Methods Seventy-five rats were randomly divided into 3 groups: normal control group, SAP group and RSM treatment group, which were injected with normal saline, normal saline or RSM in the peritoneal cavity, respectively. The model of SAP rats was made by injecting L-arginine into peritoneal cavity and by subcutaneous injection at the same time. The concentrations of amylase in plasma and in ascites were measured respectively, and the expression of NF-κB in pancreas tissues was determined by immunohistochemistry. Results The levels of amylase in plasm and ascites in SAP group and RSM treatment group increased significantly with the increased expression of NF-κB in pancreas tissue, but it was also found that both the level of amylase and the expression of NF-κB in RSM treatment group were significantly lower compared with those in SAP group, and the survival time of RSM treatment group was longer than SAP group with less pathological injury in the pancreas tissues. Conclusion RSM may be effective for the treatment of pancreatitis by degrading the expression of NF-κB.

          Release date:2016-09-08 11:49 Export PDF Favorites Scan
        • 中藥配合醋酸曲安奈德注射液治療膝骨性關節炎的療效觀察

          目的:觀察自擬中藥方劑配合醋酸曲安奈德注射液治療膝關節骨性關節炎與單獨應用曲安奈德注射液治療的療效比較。方法:我科來診60例先后隨機分成治療組和對照組,治療組30例,對照組30例。兩組均行膝關節腔內注射醋酸曲安奈德注射液,每周1次,治療組加服自擬中藥方,每日1劑,每療程7周,共治療2個療程,治療后隨訪,分別于第1、2療程后進行優良率療效評定。結果:經過1個療程治療后,治療組優良率(87%)優于對照組優良率(67%);經過2個療程后,療效評定治療組優良率(97%)優于對照組優良率(83%)。結論:中藥配合醋酸曲安奈德注射液治療膝骨性關節炎的療效優于單獨使用醋酸曲安奈德注射液進行治療,中藥方劑配合醋酸曲安奈德注射液治療膝關節骨性關節炎具有明確的療效。

          Release date:2016-09-08 10:02 Export PDF Favorites Scan
        • 直肌止點注射地塞米松致視網膜動脈痙攣一例

          Release date:2016-09-02 05:58 Export PDF Favorites Scan
        29 pages Previous 1 2 3 ... 29 Next

        Format

        Content

      3. <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
          <b id="1ykh9"><small id="1ykh9"></small></b>
        1. <b id="1ykh9"></b>

          1. <button id="1ykh9"></button>
            <video id="1ykh9"></video>
          2. 射丝袜